↓ Skip to main content

Deep Brain Stimulation of the Subthalamic Nucleus, but not Dopaminergic Medication, Improves Proactive Inhibitory Control of Movement Initiation in Parkinson's Disease

Overview of attention for article published in Neurotherapeutics, January 2013
Altmetric Badge

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
100 Mendeley
Title
Deep Brain Stimulation of the Subthalamic Nucleus, but not Dopaminergic Medication, Improves Proactive Inhibitory Control of Movement Initiation in Parkinson's Disease
Published in
Neurotherapeutics, January 2013
DOI 10.1007/s13311-012-0166-1
Pubmed ID
Authors

Emilie Favre, Bénédicte Ballanger, Stéphane Thobois, Emmanuel Broussolle, Philippe Boulinguez

Abstract

Slowness in movement initiation is a cardinal feature of Parkinson's disease (PD) that is still poorly understood and unsuccessfully alleviated by standard therapies. Here, we raise this major clinical issue within the framework of a novel theoretical model that allows a better understanding of the basic mechanisms involved in movement initiation. This model assumes that movement triggering is inhibited by default to prevent automatic responses to unpredictable events. We investigated to which extent the top-down control necessary to release this locking state before initiating actions is impaired in PD and restored by standard therapies. We used a cue-target reaction time task to test both the ability to initiate fast responses to targets and the ability to refrain from reacting to cues. Fourteen patients with dopaminergic (DA) medication and 11 with subthalamic nucleus (STN) stimulation were tested on and off treatment, and compared with 14 healthy controls. We found evidence that patients withdrawn from treatment have trouble voluntarily releasing proactive inhibitory control; while DA medication broadly reduces movement initiation latency, it does not reinstate a normal pattern of movement initiation; and stimulation of the STN specifically re-establishes the efficiency of the top-down control of proactive inhibition. These results suggest that movement initiation disorders that resist DA medication are due to executive, not motor, dysfunctions. This conclusion is discussed with regard to the role the STN may play as an interface between non-DA executive and DA motor systems in cortico-basal ganglia loops.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 100 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
France 2 2%
Italy 1 1%
Turkey 1 1%
China 1 1%
India 1 1%
Unknown 91 91%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 18%
Student > Ph. D. Student 16 16%
Student > Master 10 10%
Student > Bachelor 10 10%
Other 5 5%
Other 15 15%
Unknown 26 26%
Readers by discipline Count As %
Psychology 23 23%
Medicine and Dentistry 13 13%
Neuroscience 12 12%
Agricultural and Biological Sciences 10 10%
Engineering 4 4%
Other 7 7%
Unknown 31 31%